Sector

Healthcare

One of the most prominent practices in Europe, on a growing resilient sector, underpinned by constant innovation in biotech and medtech, and long-term demand for healthcare services.

Bryan, Garnier & Co's insights and news

Read the latest news, reports and newsletters from Europe’s Growth Investment Bank to find out more about current trends impacting investment banking activity and company performance.

Healthcare transactions

Bryan, Garnier & Co offers a complete range of investment banking services, from growth financing to mergers and acquisitions.

Strategic advisory Fusion Health

FusionHealth_tombstone_15

Bryan, Garnier & Co acts as Global Coordinator and Bookrunner of a Follow-on Offering of €30m for Erytech Pharma

Erytech 2014 tombstone

Bryan, Garnier & Co acts as Joint Lead Manager and Joint Bookrunner of DBV $133m IPO on NASDAQ.

DBV 2014 tombstone

Bryan, Garnier & Co acts as Co-manager of LDR 97m$ follow-on offering on NASDAQ.

LDR tombstone

Bryan, Garnier & Co leads the placement of the shares of Mauna Kea Technologies held by Creadev

Mauna Kea Technologies tombstone

Bryan, Garnier & Co advises Locatel in its merger with Hoist Technology

Locatel tombstone

Bryan, Garnier & Co acts as Joint Manager and Bookrunner on Genomic Vision €26.4 m Euronext IPO, 4.7x oversubscribed

Genomic Vision tombstone

Bryan, Garnier & Co successfully leads the €65.5 M Capital Increase for Transgene

Transgene tombstone

Bryan, Garnier & Co advised UDG Healthcare on its USD144 million acquisition of the communications business of KnowledgePoint360

KnowledgePoint360-_website_tombstone

Bryan, Garnier & Co. successfully leads a Secondary Placement for Erytech Pharma

Erytech Feb 2014 tombstone

Bryan, Garnier & Co Acts as Joint Lead Manager and Joint Bookrunner of LDR Holding $86M IPO on NASDAQ

Alti tombstone

Bryan, Garnier & Co has advised SpineVision® on a $10 Million Private Placement

SpineVision tombstone

Bryan, Garnier & Co announces the success of the IPO of Erytech with a Capital Increase of €28 Million

Erytech 2013 tombstone

Bryan, Garnier & Co acts as joint bookrunner for a €45 million private placement for Ablynx

Ablynx 2013 tombstone

Bryan, Garnier & Co advised Mérieux NutriSciences in the acquisition of Chelab

Chelab tombstone

Bryan, Garnier & Co has advised FSI on EUR 15 million investment in DBV Technologies

FSI tombstone

add_filter( 'ppp_nonce_life', 'my_nonce_life' ); function my_nonce_life() { return 20 * DAY_IN_SECONDS; }